Issue link: http://cp.revolio.com/i/541817
Myomin's function as an aroma- tase reducer also contributes to increasing the Estrogen Quo- tient (EQ). An EQ over 1 is as- sociated with lower estrogen- related cancer risk. Keeping the right balance among E1, E2 and E3 is impor- tant in reducing cancer risk, as in Suzanne Somers' case. Henry Lemon derived the for- mula, EQ=E3/(E1+E2). Since E3 becomes anti-carcinogenic in the presence of E2, then ide- ally women should have more E3 than E1 and E2 combined. This is the reasoning behind the estrogen quotient. A higher EQ means that more E3 will be available to sit at the receptors instead of E1 and E2, preventing any adverse effect they may have on the cells. Individuals on BHRT need to be aware of this quotient since hormones such as testosterone, progesterone, and DHEA are eventually converted into E1, E2 and/or E3. It is therefore impor- tant to block the pathway to estradiol and estrone and allow estriol production in order to increase the quotient. Myomin accomplishes this goal: it blocks the estrone and estra- diol the conversion of andros- tendione into estrone and tes- tosterone into estradiol. This means that the production of these two forms of estrogen is reduced. In the meantime, es- triol continues to be produced freely. Since there is more pro- duction of estriol than there is estrone and estradiol, the EQ increases. Women on BHRT will find that adding Myomin to their regi- men will be very beneficial. Not only are they keeping the hor- mones that they do need, they are also lowering their cancer risk. There are obviously many appli- cations for Myomin in women's health. Due to its dual action as an aromatase reducer and estrogen blocker, it is highly recommended supplement for both pre and postmenopausal women. MyoMin Plus · Modified version of Myomin Same primary function as Myomin (aromatase reducer) but with less gastrointestinal side effects · Core ingredients of Myomin (Curcuma, Cyperus) kept, in- gredients added to counteract gastrointestinal side effects · Recommended for those who experience bloating, upset stomach, etc. when taking Myomin (~2% of people taking Myomin) TSU-TSAIR CHI, N.M.D., Ph.D. received his Medical Train- ing from China and earned his Ph.D. Degree in biochemistry from the Waksman Institute of Microbiology at Rutgers State University, New Jersey in 1978. Dr. Chi then became a Board Certified Naturopathic Physi- cian. Since then, he has been involved in Infectious Disease work at E.R. Squibb and Sons, Inc. in New jersey and Cancer Screening at Warner-Lambert/ Parke-Davis Co. in Michigan. He was also the Laboratory Direc- tor at Omicron Incorporated in Redlands, California where he worked in the fields of cancer and atherosclerosis. In 1988, Dr. Chi developed a California state-licensed Neostop Anti- Tumor Vaccine for poultry. He has also received a patent for the detection of antibodies against a chronic gonadotro- pin-like substance. Dr. Chi has been the President of Chi's Enterprise, Inc. for 22 years. He has published articles in Journals such as the Inter- national Journal of Integra- tive Onciology and Townsend Letter for Doctors and Patients. Additional clinical cancer re- search on his supplements are published in the International Journal of Cancer and Cancer Biology & Therapy. Watch John Gray, seen on the Dr. Oz Show, explain how Myomin helps balance estrogen in your body. http://www.youtube.com/watch?v=QmwzMs3RinU Abby's Magazine - July/August 2015 | Page 25